The prognostic role of PRUNE2 in leiomyosarcoma
Chinese Journal of Cancer · 05.12.2013 · 32 (12) · 648-652
DOI: 10.5732/cjc.013.10069 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chinese Journal of Cancer, erschienen am 05.12.2013. Verfasst von Lin-Ru Zhao und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bone and Soft Tissue Tumor, Tianjin Medical University Cancer Hospital & Institute, Tianjin 300060, P. R. China. jilongyang@yahoo.com. …. Die Arbeit wurde bisher 14-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Bone and Soft Tissue Tumor, Tianjin Medical University Cancer Hospital & Institute, Tianjin 300060, P. R. China. jilongyang@yahoo.com. chenkexin1963@yahoo.com.
Zitieren
APA
Zhao, L. R., Tian, W., Wang, G. W., Chen, K. X., & Yang, J. L. (2013). The prognostic role of PRUNE2 in leiomyosarcoma. Chinese Journal of Cancer, 32(12), 648-652. https://doi.org/10.5732/cjc.013.10069
Vancouver
Zhao LR, Tian W, Wang GW, Chen KX, Yang JL. The prognostic role of PRUNE2 in leiomyosarcoma. Chinese Journal of Cancer. 2013;32(12):648-652. doi:10.5732/cjc.013.10069
BibTeX
@article{Zhao2013,
author = {Zhao, Lin-Ru and Tian, Wei and Wang, Guo-Wen and Chen, Ke-Xin and Yang, Ji-Long},
title = {The prognostic role of PRUNE2 in leiomyosarcoma},
journal = {Chinese Journal of Cancer},
year = {2013},
volume = {32},
number = {12},
pages = {648--652},
doi = {10.5732/cjc.013.10069}
}
EUVIMED